ESMO 2018

Oct 19, 2018

The Epic Sciences team attended the European Society for Medical Oncology 2018 Congress in Munich, Germany from October 19 – October 23, 2018.

Poster Presentations: Monday, October 22nd – 12:45 – 13:45 in Hall A3 – Poster Area Networking Hub

836PEvaluation of the clinical utility of the nuclear-localized AR-V7 biomarker in CTCs in the context of physician intuition measured through physician therapy choice propensity and patient risk.

Authors: H.I. Scher, R.P. Graf, M. Hulling, E. Carbone, R. Dittamore

842P – CTC-based biomarkers & PSMA-targeted imaging in patients with metastatic castrate-resistant prostate cancer (mCRPC).

Authors: M.J. Morris, N.J. Vogelzang, O. Sartor, A. Armour, R. Messmann, M. Groaning, A. Robarts, A.W. Tolcher, M. Gordon, H.M. Babiker, P. Kuo, M. Kearney, A. Jendrisak, Y. Wang, M. Landers, D.P. Petrylak

848POverall survival (OS) implications for patients with mCRPC through coverage and adoption of nuclear AR-V7 testing by healthcare systems.

Authors: J. Hornberger, R.P. Graf, M. Hulling, G. Attard, A. Allan, R. Dittamore, H.I. Scher